Literature DB >> 28151819

Epidemiology of Cardiac Arrest During Hospitalization for Delivery in Canada: A Nationwide Study.

Mrinalini Balki1, Shiliang Liu, Juan Andrés León, Leyla Baghirzada.   

Abstract

BACKGROUND: Cardiac arrest in pregnancy is a rare and devastating condition with high mortality and morbidity. The objective of this study was to generate information about maternal cardiac arrest in Canada by examining the frequency, temporal incidence, associated conditions, potential etiologies, and survival rates.
METHODS: This retrospective population-based study used hospitalization data from the discharge abstract database of the Canadian Institute for Health Information relating to obstetric deliveries in Canada from April 1, 2002, to March 31, 2015. The data were accessed through the Public Health Agency of Canada's (PHAC) Canadian Perinatal Surveillance System. Cases of cardiac arrest were identified using the diagnostic and intervention codes from the International Statistical Classification of Diseases and the Canadian Classification of Health Interventions, respectively. Data on patient demographics, medical and obstetrical conditions, and potential etiologies of cardiac arrest were collected. Multivariable logistic regression analysis was used to identify conditions associated with cardiac arrest.
RESULTS: There were 286 cases of maternal cardiac arrest among 3,568,597 hospitalizations for delivery during the 13-year period. A total of 204 (71.3%) women survived to hospital discharge (95% confidence interval, 65.7%-76.5%). There was no significant variation in the incidence of cardiac arrest or survival from arrest over time or across provinces. Among the pre-existing conditions, hypertensive disorders of pregnancy, gestational diabetes, malignancy, and diseases of the respiratory and nervous system were found to be significantly associated with cardiac arrest. Among the obstetrical conditions, placental abnormalities and polyhydramnios were associated with cardiac arrest. The common potential etiologies included postpartum hemorrhage, heart failure, amniotic fluid embolism, and complications of anesthesia.
CONCLUSIONS: In this first Canadian study, the incidence of cardiac arrest during pregnancy was found to be 1:12,500 deliveries. The survival rate reported in our study is higher than reported previously in other countries. Our study findings contribute to better inform the development and implementation of policies and programs in an effort to prevent and manage this condition.

Entities:  

Mesh:

Year:  2017        PMID: 28151819     DOI: 10.1213/ANE.0000000000001877

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  5 in total

1.  The 2017 Virginia Apgar Collection Part II: Maternal Safety and Abstract Reasoning.

Authors:  Brian T Bateman; Richard Smiley
Journal:  Anesth Analg       Date:  2017-03       Impact factor: 5.108

2.  Anesthesia-related adverse events in obstetric patients: a population-based study in Canada.

Authors:  Leyla Baghirzada; David Archer; Andrew Walker; Mrinalini Balki
Journal:  Can J Anaesth       Date:  2021-09-07       Impact factor: 5.063

3.  Use of Post-Acute Care Services and Readmissions After Acute Myocardial Infarction Complicated by Cardiac Arrest and Cardiogenic Shock.

Authors:  Saraschandra Vallabhajosyula; Stephanie R Payne; Jacob C Jentzer; Lindsey R Sangaralingham; Kianoush Kashani; Nilay D Shah; Abhiram Prasad; Shannon M Dunlay
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-02-08

4.  Effect of maternal positioning during cardiopulmonary resuscitation: a systematic review and meta-analyses.

Authors:  Naosuke Enomoto; Tomoyuki Yamashita; Marie Furuta; Hiroaki Tanaka; Edmond S W Ng; Shigetaka Matsunaga; Atsushi Sakurai
Journal:  BMC Pregnancy Childbirth       Date:  2022-02-25       Impact factor: 3.007

5.  Maternal cardiac arrest secondary to choriosepsis after preterm premature rupture of membranes.

Authors:  Morgan Burgoyne; Duncan Webster; Naila Ramji
Journal:  CMAJ       Date:  2022-09-12       Impact factor: 16.859

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.